Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 6, 1999

View Archived Issues

OECD's Role, Stature In GMO Issues To Be More Prominent

GPC Enters Broad $20M Deal With Hoechst In Osteoarthritis

Europe's Largest Biotech Fair Attracts 10,000 To Hanover

Neurosearch Plans To Spin Out Work In Cell And Gene Therapy

Quadrant Stops Development Of Oral Cyclosporin Product

Heart Drug Show Promise In Degenerative Eye Disease

MDS Enters Emerging Field, Forms Proteomics Company

Antisoma Seeks Partner For Theragyn While It Has Money

AnalytiCon AG: Fast Lane to Drugs From Natural Compounds

French Researchers Identify Cavernous Angiomas Gene

XTL's Fully Human Antibody Enters Phase I Study In HBV

EU Requests Labeling For Genetically Modified Feeds

Cerep, RPR Sign New Deal, Amend Existing Collaboration

Australian Tax Changes Will Boost Biotech Investments

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.